Clinical AI Adoption: 2026 Healthcare Report
Status of FDA-cleared AI medical devices, clinical decision support systems, and diagnostic AI. Adoption rates across radiology, pathology, cardiology, and primary care.
Key Data
Analysis
FDA-cleared AI medical devices surpassed 900 in 2025, with radiology accounting for 75% of clearances. Clinical deployment, however, lags significantly behind regulatory approval — only 35% of cleared devices are in active clinical use.
The adoption gap stems from integration challenges (AI tools that do not fit existing clinical workflows), trust deficits (clinicians who do not trust AI recommendations for high-stakes decisions), and reimbursement uncertainty (payers who do not have clear billing codes for AI-assisted procedures).
The most successful deployments share three characteristics: they reduce clinician workload rather than adding steps, they present AI output as supporting evidence rather than decisions, and they integrate with existing EHR systems rather than requiring new interfaces.
Ehsan's Analysis
The 35% deployment rate tells the real story of healthcare AI: regulatory clearance is the easy part. Clinical integration is the hard part. The winning products are the ones that make radiologists faster, not the ones that try to replace them. A radiologist who reads 80 scans/day reads 120/day with AI assistance. That is a 50% productivity gain without threatening anyone's job. The products that positioned as "replacement" technology are the ones sitting unused on hospital servers.
Ehsan Jahandarpour
AI Growth Strategist & Fractional CMO
Forbes Top 20 Growth Hacker · TEDx Speaker · 716 Academic Citations · Ex-Microsoft · CMO at FirstWave (ASX:FCT) · Forbes Communications Council